| Bioactivity | Aloisine RP106 (compound 38) is a potent inhibitor of Cdk1/cyclin B, Cdk5/p25, and GSK3 with IC50s of 0.70µM, 1.5µM, 0.92 µM, respectively[1]. |
| Name | Aloisine RP106 |
| CAS | 496864-15-4 |
| Formula | C17H19N3O |
| Molar Mass | 281.35 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Yvette Mettey, et al. Aloisines, a new family of CDK/GSK-3 inhibitors. SAR study, crystal structure in complex with CDK2, enzyme selectivity, and cellular effects. J Med Chem. 2003 Jan 16;46(2):222-36. |
Aloisine RP106
CAS: 496864-15-4 F: C17H19N3O W: 281.35
Aloisine RP106 (compound 38) is a potent inhibitor of Cdk1/cyclin B, Cdk5/p25, and GSK3 with IC50s of 0.70µM, 1.5µM, 0
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.